Revenue Growth
Enerpac's total revenue increased 2.3% in the first quarter of 2025, with a 2.3% year-over-year increase in the IT&S business.
Cortland Biomedical Performance
Reported a year-over-year revenue increase of 2.6%, contributing to the company's overall growth.
Strong Balance Sheet
Enerpac's net debt was $63 million, resulting in net debt leverage of 0.5x adjusted EBITDA, with total liquidity of $529 million.
Successful Integration of DTA Acquisition
The integration of DTA contributed more than $3 million in revenue and $5 million in order volume, with expectations of EUR 20 million in sales for the full year.
Positive Outlook in EMEA and APAC Regions
Continued year-over-year growth in the EMEA region and return to growth in the APAC region, despite macroeconomic challenges.